Home > News > Diversa Granted U.S. Patent
August 11th, 2003
Diversa Granted U.S. Patent
Diversa Corporation (Nasdaq: DVSA) today announced that it has been issued U.S. Patent No. 6,602,675, expanding its proprietary position for identifying biologically active molecules from the environment. The patent is directed to small molecule and enzyme discovery from both cultured and uncultured filamentous fungi and bacteria using high-throughput fluorescent screening. In addition to their utility for discovering novel enzyme products for agricultural and chemical applications, the technologies covered in this patent are an important part of Diversa’s small molecule discovery platform, which includes high-throughput culturing and recombinant expression for developing natural product drug candidates.
Amorphous Coordination Polymer Particles as alternative to classical nanoplatforms for nanomedicine October 30th, 2014
Lomiko Signs Licensing Agreement to Produce and Supply Power Converter Systems to E-Commerce Customers October 29th, 2014
Researchers patent a nanofluid that improves heat conductivity October 22nd, 2014
Nanodevices for clinical diagnostic with potential for the international market: The development is based on optical principles and provides precision and allows saving vital time for the patient October 15th, 2014